Calton & Associates, Inc. Abbott Laboratories Transaction History

Calton & Associates, Inc.

$250 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 18, 2023	BUY	$95.06 - $111.52 $53,328 - $62,562	561 Added 24.41%	2,859 $0
Q3 2022 Oct 31, 2022	SELL	$96.76 - $112.03 $11,224 - $12,995	-116 Reduced 4.81%	2,298 $222,000
Q2 2022 Jul 12, 2022	SELL	$102.07 - $123.37 $22,353 - $27,018	-219 Reduced 8.32%	2,414 $262,000
Q1 2022 Apr 12, 2022	SELL	$114.02 - $139.04 $171,144 - $208,699	-1,501 Reduced 36.31%	2,633 $311,000
Q4 2021 Jan 13, 2022	SELL	$115.53 - $141.46 $179,071 - $219,263	-1,550 Reduced 27.27%	4,134 $581,000
Q3 2021 Nov 05, 2021	SELL	$116.66 - $129.06 $139,875 - $154,742	-1,199 Reduced 17.42%	5,684 $671,000
Q2 2021 Aug 11, 2021	SELL	$105.79 - $124.53 $35,016 - $41,219	-331 Reduced 4.59%	6,883 $799,000
Q1 2021 May 03, 2021	SELL	$108.84 - $128.23 $97,302 - $114,637	-894 Reduced 11.03%	7,214 $865,000
Q4 2020 Jan 25, 2021	BUY	$105.0 - $114.42 $18,585 - $20,252	177 Added 2.23%	8,108 $888,000
Q3 2020 Oct 30, 2020	BUY	$91.64 - $111.29 $78,535 - $95,375	857 Added 12.11%	7,931 $863,000
Q2 2020 Aug 10, 2020	SELL	$76.57 - $98.0 $6,508 - $8,330	-85 Reduced 1.19%	7,074 $647,000
Q1 2020 Apr 30, 2020	SELL	$62.82 - $91.86 $28,834 - $42,163	-459 Reduced 6.03%	7,159 $565,000
Q4 2019 Feb 03, 2020	SELL	$78.51 - $87.4 $55,506 - $61,791	-707 Reduced 8.49%	7,618 $662,000
Q3 2019 Nov 07, 2019	SELL	$81.84 - $88.74 $54,259 - $58,834	-663 Reduced 7.38%	8,325 $697,000
Q2 2019 Jul 09, 2019	BUY	$72.88 - $85.0 $104,655 - $122,060	1,436 Added 19.01%	8,988 $756,000
Q1 2019 Apr 25, 2019	BUY	$66.22 - $80.06 $264 - $320	4 Added 0.05%	7,552 $604,000
Q4 2018 Feb 11, 2019	BUY	$65.56 - $74.27 $188,157 - $213,154	2,870 Added 61.35%	7,548 $546,000
Q3 2018 Oct 24, 2018	BUY	$60.81 - $73.36 $9,121 - $11,004	150 Added 3.31%	4,678 $343,000
Q2 2018 Aug 10, 2018	SELL	$57.57 - $63.54 $237,706 - $262,356	-4,129 Reduced 47.7%	4,528 $294,000
Q1 2018 Apr 17, 2018	BUY	$56.27 - $63.62 $138,367 - $156,441	2,459 Added 39.67%	8,657 $519,000
Q4 2017 Feb 05, 2018	BUY	$53.68 - $57.47 $332,708 - $356,199	6,198	6,198 $367,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.8 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.4 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.03 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.74 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.28 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Calton & Associates, Inc. with notifications on news.

Account